Four top Warren Buffett picks are perfect now for growth and income investors as they come with solid and dependable ...

Gilead plans to go straight to Phase III studies for once-yearly lenacapavir, while GSK and Viiv will push forward with their ...

Treatments for autoimmune diseases and those in orphan markets are on the up and up, as are drugmakers’ first launches, ...

The Rebels beat Air Force in the Mountain West tournament despite giving just six players heavy minutes. They have to turn ...